Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Xiaoxiao Zuo"'
Autor:
Xiaoxiao Zuo, Xiaohan Zhao, Xiaofei Zhang, Qingyuan Li, Xingyu Jiang, Shumei Huang, Xuwei Chen, Xiangfu Chen, Weihua Jia, Hequn Zou, Dongni Shi, Xueke Qian
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-16 (2024)
Abstract Background Cancer metastasis remains a major challenge in the clinical management of triple-negative breast cancer (TNBC). The NF-κB signaling pathway has been implicated as a crucial factor in the development of metastases, but the underly
Externí odkaz:
https://doaj.org/article/cb78a0c0ad7244c9bf7b7d070c1fe19e
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Exploring the mechanism of breast cancer metastasis and searching for new drug therapeutic targets are still the focuses of current research. RNA-binding proteins (RBPs) may affect breast cancer metastasis by regulating alternative splicing
Externí odkaz:
https://doaj.org/article/e517bb9553544f3ba515a42b51c5b1a3
Autor:
Jinfeng Chen, An Zhang, Anzheng Nie, Xiaoxiao Zuo, Lei Zhang, Yuxue Jiao, Lulu Wang, Yang Yang, Kun Liu, Xinli Xue, Yuanyuan Zhuang, Yansha Meng, Jing-Hua Yang
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background:Stephania tetrandra has been used for treating rheumatic diseases for thousands of years in rural areas of China. Several studies have found that tetrandrine and fangchinoline can inactivate the PI3K/Akt signaling pathway by reducing the e
Externí odkaz:
https://doaj.org/article/16a611a7bf8b49a4a5b214d8dd2e9ce3
Autor:
Jing Yang, Meilian Dong, Yifang Shui, Yue Zhang, Zhigang Zhang, Yin Mi, Xiaoxiao Zuo, Li Jiang, Ke Liu, Zheyan Liu, Xiaobin Gu, Yonggang Shi
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Programmed death-ligand 1 (PD-L1) was the first identified ligand of programmed death-1 (PD-1). PD-1/PD-L1 interactions inhibit T cell-mediated immune responses, limit cytokine production, and promote tumor immune escape. Recently
Externí odkaz:
https://doaj.org/article/e167a51db1764578ad1c184520590e29
Publikováno v:
Molecular Medicine, Vol 26, Iss 1, Pp 1-10 (2020)
Abstract Purpose Genetic variants play a critical role in the development of breast cancer. This investigation aimed to explore the association between CASC16 polymorphisms and breast cancer susceptibility. Methods We conducted a case-control study o
Externí odkaz:
https://doaj.org/article/44f25b72f2da440b8c9d09342b727e67
Autor:
Yin Mi, Pengwei Lv, Fang Wang, Lin Li, Mingzhi Zhu, Yanyan Wang, Yingying Zhang, Lele Liu, Qinchen Cao, Meilian Dong, Yonggang Shi, Ruitai Fan, Jingruo Li, Yuanting Gu, Xiaoxiao Zuo
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Purpose: To investigate the efficacy of targeted intraoperative radiotherapy (TARGIT) vs. conventional external beam radiotherapy (EBRT) in Chinese patients with breast cancer.Methods: We retrospectively analyzed breast cancer patients who underwent
Externí odkaz:
https://doaj.org/article/e59fced4a68946ddbe1b4533ee36a55b
Autor:
Miao Li, Chenli Yue, Xiaoxiao Zuo, Guoquan Jin, Guanying Wang, Hulin Guo, Fang Wu, Shangke Huang, Xinhan Zhao
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232174 (2020)
BackgroundPrevious studies have reported on several genetic variants related to breast cancer, but a substantial proportion of mutation loci have not yet been identified. In the current study, we aimed to evaluate the association between single nucle
Externí odkaz:
https://doaj.org/article/e74d55af805546278d0f7bfd924bce32
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 7, Iss 8, Pp n/a-n/a (2019)
Abstract Background Breast cancer (BC) is the most common cancer in women and the second leading cause of cancer‐related deaths among women worldwide. Single nucleotide polymorphisms (SNPs) in cytokine genes have been shown to alter their expressio
Externí odkaz:
https://doaj.org/article/c2bf269ef5e7459dbd3e2f4552a9f374
Autor:
Qian Ning, Caigang Liu, Lei Hou, Min Meng, Xiaojin Zhang, Minna Luo, Shan Shao, Xiaoxiao Zuo, Xinhan Zhao
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65217 (2013)
Vascular endothelial growth factor receptor-1 (VEGFR-1 or Flt-1), a tyrosine kinase receptor, is highly expressed in breast cancer tissues, but near absent in normal breast tissue. While VEGFR-1 expression is associated with poor prognosis of women w
Externí odkaz:
https://doaj.org/article/aba9031e80134fe8a65a702d9eaf6d83
Autor:
Ya, Yang, Narasimha M, Beeraka, Junqi, Liu, Xiaoxiao, Zuo, Xin, Wang, Tingxuan, Li, Ruitai, Fan
Publikováno v:
Current Pharmaceutical Design. 28:3404-3412
Background: Immune checkpoint inhibitors (ICIs), specifically programmed cell death receptor-1/ligand 1 (PD-1/L1) inhibitors, have shown potential pharmacological efficacy in several cancers. Nonetheless, data pertinent to their therapeutic efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3592fd2c670c6788adf199086f009fe1
https://doi.org/10.2174/1381612828666220921151750
https://doi.org/10.2174/1381612828666220921151750